ES8400742A1 - Procedimiento de preparacion de las dibenzooxepinas sustituidas y de sus sales de adicion con un acido mineral u organi-co. - Google Patents

Procedimiento de preparacion de las dibenzooxepinas sustituidas y de sus sales de adicion con un acido mineral u organi-co.

Info

Publication number
ES8400742A1
ES8400742A1 ES519463A ES519463A ES8400742A1 ES 8400742 A1 ES8400742 A1 ES 8400742A1 ES 519463 A ES519463 A ES 519463A ES 519463 A ES519463 A ES 519463A ES 8400742 A1 ES8400742 A1 ES 8400742A1
Authority
ES
Spain
Prior art keywords
medicaments
processes
preparation
methods
pharmaceutical compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES519463A
Other languages
English (en)
Other versions
ES519463A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Science Union et Cie
Original Assignee
Science Union et Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Science Union et Cie filed Critical Science Union et Cie
Publication of ES8400742A1 publication Critical patent/ES8400742A1/es
Publication of ES519463A0 publication Critical patent/ES519463A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D321/00—Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups C07D317/00 - C07D319/00
    • C07D321/02—Seven-membered rings
    • C07D321/10—Seven-membered rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D327/00—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D327/02—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms one oxygen atom and one sulfur atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

PROCEDIMIENTO DE PREPARACION DE LAS DIBENZOOXEPINAS SUSTITUIDAS Y DE SUS SALES DE ADICION CON UN ACIDO MINERAL U ORGANICO.SE SAPONIFICA UN COMPUESTO METILIDIENICO DE FORMULA (II) DONDE R Y RK SON IDENTICOS O DIFERENTES Y REPRESENTAN HIDROGENO, ALCOHILO INFERIOR, ALCOXI INFERIOR, TRIFLUOROMETILO O UN GRUPO ALCOHILTIO, A. ES OXIGENO O AZUFRE Y M Y M IGUALES O DIFERENTES, REPRESENTAN UN NUMERO ENTERO DE 1 O 2, EN MEDIO ALCALINO PARA FORMAR UN DERIVADO AMINADO DE FORMULA (IV) EN DONDE R1 Y R2 SON IGUALES O DIFERENTES Y REPRESENTAN HIDROGENO, ALCOHILO INFERIOR, ARALCOHILO INFERIOR O UN HIDROXI ALCOHILOINFERIOR, EN PRESENCIA DE UN AGENTE DE FUNCIONALIZACION DEL CARBOXILO PARA FORMAR LA AMIDA METILIDENICA DE FORMULA (V) QUE SE PUEDE REDUCIR O HIDROGENAR EN UN DERIVADO ETILAMINADO DE FORMULA GENERAL (I).SE UTILIZAN COMO AGENTES ANTIDEPRESORES, ANXIOLITICOS Y SEDANTES.
ES519463A 1980-04-10 1983-02-01 Procedimiento de preparacion de las dibenzooxepinas sustituidas y de sus sales de adicion con un acido mineral u organi-co. Granted ES519463A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8008023A FR2480283A1 (fr) 1980-04-10 1980-04-10 Nouveaux derives tricycliques, leurs procedes de preparation et leur utilisation comme medicament

Publications (2)

Publication Number Publication Date
ES8400742A1 true ES8400742A1 (es) 1983-11-16
ES519463A0 ES519463A0 (es) 1983-11-16

Family

ID=9240699

Family Applications (2)

Application Number Title Priority Date Filing Date
ES500942A Expired ES8306483A1 (es) 1980-04-10 1981-03-31 Procedimiento de preparacion de las dibezooxepinas sustituidas y de sus sales de adicion con un acido mineral u organico
ES519463A Granted ES519463A0 (es) 1980-04-10 1983-02-01 Procedimiento de preparacion de las dibenzooxepinas sustituidas y de sus sales de adicion con un acido mineral u organi-co.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES500942A Expired ES8306483A1 (es) 1980-04-10 1981-03-31 Procedimiento de preparacion de las dibezooxepinas sustituidas y de sus sales de adicion con un acido mineral u organico

Country Status (23)

Country Link
US (1) US4459306A (es)
EP (1) EP0041410B1 (es)
JP (1) JPS56158780A (es)
AR (1) AR229026A1 (es)
AT (1) ATE5257T1 (es)
AU (1) AU538054B2 (es)
CA (1) CA1181068A (es)
DD (1) DD158242A5 (es)
DE (1) DE3161358D1 (es)
DK (1) DK159981A (es)
ES (2) ES8306483A1 (es)
FI (1) FI811059L (es)
FR (1) FR2480283A1 (es)
GR (1) GR75194B (es)
IL (1) IL62622A (es)
MA (1) MA19113A1 (es)
NO (1) NO811229L (es)
NZ (1) NZ196774A (es)
OA (1) OA06779A (es)
PT (1) PT72833B (es)
SU (1) SU1106444A3 (es)
YU (1) YU92481A (es)
ZA (1) ZA812379B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2094790B (en) * 1981-03-13 1985-10-09 Spofa Vereinigte Pharma Werke Tricycle compounds
ATE35262T1 (de) * 1982-09-30 1988-07-15 Merck Frosst Canada Inc 6h-dibenz(b,e)(1,4)oxathiepin-derivate und deren herstellung.
KR100330942B1 (ko) * 1994-03-02 2002-11-16 악조 노벨 엔.브이. 설하또는협측투여용약학조성물
JP4006796B2 (ja) 1997-11-17 2007-11-14 株式会社日立製作所 個人情報管理方法および装置
ATE445838T1 (de) 2001-07-25 2009-10-15 Raptor Pharmaceutical Inc Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
US6683072B1 (en) 2003-02-04 2004-01-27 Vela Pharmaceuticals, Inc. Compositions and methods for treatment of irritable bowel syndrome and nonulcer dyspepsia
US20050227961A1 (en) * 2004-04-08 2005-10-13 Vela Pharmaceuticals, Inc. Compositions and methods for treatment of neuropathic pain, fibromyalgia and chronic fatigue syndrome
DK1889198T3 (da) 2005-04-28 2015-02-09 Proteus Digital Health Inc Farma-informatiksystem
WO2008036682A2 (en) 2006-09-18 2008-03-27 Raptor Pharmaceutical Inc. Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
ES2728225T3 (es) 2009-02-20 2019-10-23 2 Bbb Medicines B V Sistema de administración de fármacos a base de glutatión
US8445002B2 (en) 2009-05-06 2013-05-21 Laboratory Skin Care, Inc. Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
CN111377901A (zh) * 2018-12-27 2020-07-07 华东理工大学 一种缩酚酸环醚类化合物及其制备方法与用途
JP2024513500A (ja) * 2021-04-10 2024-03-25 サノビオン ファーマシューティカルズ インク Ｔａａｒ１及びセロトニン調節剤、及び医薬組成物、並びにそれらの使用方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES274329A1 (es) * 1961-01-30 1962-06-01 Geigy Ag J R Procedimiento para la preparacion de nuevos compuestos de 1,5-benzodioxepano
FR1312891A (fr) * 1962-01-29 1962-12-21 Geigy Ag J R Nouveaux 1.5-benzo-dioxépannes et leur préparation
FR1312889A (fr) * 1962-01-29 1962-12-21 Geigy Ag J R Nouveaux benzo-dioxépannes et leur préparation
US3821249A (en) * 1970-03-13 1974-06-28 En Nom Collectif Science Union Dibenzothiazefin derivatives
US3758528A (en) * 1970-03-13 1973-09-11 Science Union & Cie Tricyclic compounds
US4039676A (en) * 1975-06-23 1977-08-02 Ciba-Geigy Corporation 2-piperidinoalkyl-1,4-benzodioxans
US4335122A (en) * 1981-03-18 1982-06-15 Hoechst-Roussel Pharmaceuticals Inc. Dihydro-dibenzoxepines-thiepines and -morphanthridones, compositions and use

Also Published As

Publication number Publication date
US4459306A (en) 1984-07-10
IL62622A (en) 1984-10-31
PT72833A (fr) 1981-05-01
OA06779A (fr) 1982-12-31
DD158242A5 (de) 1983-01-05
DE3161358D1 (en) 1983-12-15
EP0041410A1 (fr) 1981-12-09
ATE5257T1 (de) 1983-11-15
AR229026A1 (es) 1983-05-31
ES519463A0 (es) 1983-11-16
PT72833B (fr) 1982-07-26
ZA812379B (en) 1982-04-28
CA1181068A (fr) 1985-01-15
SU1106444A3 (ru) 1984-07-30
EP0041410B1 (fr) 1983-11-09
AU6934081A (en) 1981-10-15
IL62622A0 (en) 1981-06-29
MA19113A1 (fr) 1981-12-31
AU538054B2 (en) 1984-07-26
JPS56158780A (en) 1981-12-07
FR2480283B1 (es) 1983-09-23
JPS6116394B2 (es) 1986-04-30
FR2480283A1 (fr) 1981-10-16
DK159981A (da) 1981-10-11
NZ196774A (en) 1983-09-30
FI811059L (fi) 1981-10-11
GR75194B (es) 1984-07-13
YU92481A (en) 1984-02-29
ES500942A0 (es) 1983-06-01
ES8306483A1 (es) 1983-06-01
NO811229L (no) 1981-10-12

Similar Documents

Publication Publication Date Title
DE69713526D1 (de) Lösliche prodrugs von paclitaxel
IL72120A0 (en) 2-pyrimidinyl-1-piperazine derivatives,their preparation and pharmaceutical compositions containing them
IL68350A (en) N-glycosylated carboxamide derivatives,their preparation and their use for the treatment of animals
ES8306483A1 (es) Procedimiento de preparacion de las dibezooxepinas sustituidas y de sus sales de adicion con un acido mineral u organico
ES8800946A1 (es) Un procedimiento para preparar derivados de guanina
UA45942A (uk) 1,3-оксатіолан, його похідні, спосіб (варіанти) його одержання та фармацевтична композиція
ZA796356B (en) New hydroxypropyl-triazole compounds, their production and their medicinal use
IT1170214B (it) Composizione farmaceutica per la cura delle arteriopatie periferiche
ES8200094A1 (es) Procedimiento para la obtencion de alquilureas
DE3166084D1 (en) Tricyclic cytosine derivatives for use in pharmaceutical preparations and process for their preparation
IT8025159A0 (it) Preparato medicinale ad azione citostatica, nonche' derivati dell'acido isocianurico eprocedimento per la loro preparazione.
DE2967356D1 (en) Cephalosporin derivatives, process for their preparation and pharmaceutical compositions containing them
DE3063525D1 (en) Process for the preparation of phosphono-hydroxy-acetic acid and salts thereof and autiviral compositions containing them
DK0521057T3 (da) Farmaceutiske midler indeholdende ipriflavon, fremgangsmåde til fremstilling deraf, og relativ terapeutisk anvendelse
DE3371515D1 (en) Cycloalkyl derivatives of benzisoselenazolones, process for their preparation and pharmaceutical compositions containing them
DK527186D0 (da) Bronchodilaterende farmaceutisk praeparat
IL60323A0 (en) Pseudotrisaccharide compounds,their preparation and their medicinal use
EP0009636A3 (en) 3-chloro-6-hydroxy-5-methylbenzoic acid derivative, corresponding pharmaceutical preparations, growth promoting compositions, the use of the compounds in the treatment and prophylaxis of diseases and for promoting growth of certain animals, and their manufacture
ATE22282T1 (de) Pentacycloundecan derivate, verfahren zu ihrer herstellung, und diese enthaltende pharmazeutische zusammensetzungen.
ES8501764A1 (es) Un metodo para preparar nuevos derivados de guanina
MY103593A (en) Bicyclic compounds, their use as pharmaceuticals, their preparation, and intermediates useful in their preparation
SE7708622L (sv) 2-bensyl-perhydroazepiner, sett for framstellning derav och lekemedel, innehallande dem
KR920700633A (ko) 열 및 빛의 방사선 때문에 일어난 자동면역 질병 및 피부병에 대한 예방 및 치료 방법
GB2019720A (en) S-adenosyl-L-homocysteine and salts thereof for use in therapy
RU92016559A (ru) Производные диалкокси-пиридинилбензимидазола, фармацевтическая композиция, способ ингибирования или лечения, способ их получения, применение и промежуточные соединения